Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 6/20 | 0.35 |
| ▸ | DGKA | P23743 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9926866 | 1.00 | NAAA (0.48) | NAAAMEN1GAAKMT2APRKCA | |
| SCHEMBL45485 | 1.00 | NAAA (0.48) | NAAAMEN1GAAKMT2APRKCA | |
| SCHEMBL29413050 | 1.00 | NAAA (0.48) | NAAAMEN1GAAKMT2APRKCA | |
| SCHEMBL4867060 | 1.00 | NAAA (0.48) | NAAAMEN1GAAKMT2APRKCA | |
| SCHEMBL6298143 | 1.00 | NAAA (0.48) | NAAAMEN1GAAKMT2APRKCA | |
| SCHEMBL15299845 | 1.00 | NAAA (0.48) | NAAAMEN1GAAKMT2APRKCA | |
| SCHEMBL6298154 | 1.00 | NAAA (0.48) | NAAAMEN1GAAKMT2APRKCA | |
| SCHEMBL17085426 | 1.00 | NAAA (0.48) | NAAAMEN1GAAKMT2APRKCA | |
| SCHEMBL7118569 | 0.99 | NAAA (0.46) | NAAAMEN1GAAKMT2APRKCA | |
| SCHEMBL21582136 | 0.95 | NAAA (0.39) | NAAAMEN1GAAKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030120077-A1 | Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES PETER (US) | 2003-06-26 | — | — | US | claimed |
| US-6403681-B2 | STABILIZER FOR PLASTICS | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-06-11 | — | — | US | claimed |
| US-20020058735-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES PETER (US) | 2002-05-16 | — | — | US | claimed |
| US-20020040145-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2002-04-04 | — | — | US | claimed |
| US-20010034449-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-10-25 | — | — | US | claimed |
| US-20010031872-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-10-18 | — | — | US | claimed |
| US-20010018520-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-08-30 | — | — | US | claimed |
| US-6391949-B1 | — | — | None | — | — | US | disclosed |
| US-12426670-B2 | Midsole structure of an article of footwear including mesh | NIKE, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4008210-B1 | A KNIT TEXTILE | NIKE INNOVATE CV (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12342902-B2 | Footwear sole structure having a composite element and methods for manufacturing same | NIKE, INC. (US) | 2025-07-01 | — | — | US | disclosed |
| EP-3538699-B1 | KNIT ARTICLES AND PROCESSES FOR MAKING THE SAME | NIKE INNOVATE CV (US) | 2025-05-07 | — | — | EP | disclosed |
| US-12269208-B2 | Methods of manufacturing articles utilizing foam particles | NIKE, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| EP-1190622-A1 | Mixtures of phenolic and inorganic materials with antimicrobial activity | Ciba SC Holding AG (CH) | 2002-03-27 | — | — | EP | disclosed |
| US-20010034449-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-10-25 | — | — | US | disclosed |
| US-20010031872-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-10-18 | — | — | US | disclosed |
| US-20010020099-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-09-06 | — | — | US | disclosed |
| US-20010018520-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-08-30 | — | — | US | disclosed |
| US-20010016658-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-08-23 | — | — | US | disclosed |
| US-6271377-B1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020040145-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885MEN1 2812/4885GAA 1582/4885 |
| US-20020058735-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | OGG1, HAO2, POLH | NAAA 1048/4885MEN1 2374/4885GAA 1255/4885 |
| US-20010016658-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885MEN1 2812/4885GAA 1582/4885 |
| US-20010034449-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885MEN1 2812/4885GAA 1582/4885 |
| US-20010020099-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885MEN1 2812/4885GAA 1582/4885 |
| US-20030120077-A1 | Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith | OGG1, POLH, OGFOD1 | NAAA 925/4885MEN1 2478/4885GAA 1590/4885 |
| US-20010018520-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885MEN1 2812/4885GAA 1582/4885 |
| US-20010031872-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885MEN1 2812/4885GAA 1582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.